![Preetam Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Preetam Shah
Director of Finance/CFO at
ELICIO THERAPEUTICS, INC.
Net worth: - $ as of 2026-05-30
Profile
Preetam Shah is the founder of Saisarva LLC, founded in 2010.
Dr. Shah is currently the Treasurer, Chief Financial & Strategy Officer at Elicio Therapeutics, Inc. since 2025.
Former positions include Director-Healthcare Investment Banking at Barclays Capital, Inc., Director-Healthcare Investment Banking at Lordes Capital Ltd., Chief Financial Officer, Treasurer & Executive VP at Brainstorm Cell Therapeutics, Inc. from 2019 to 2021, Vice President-Healthcare Investment Banking at Canaccord Genuity, Inc. from 2013 to 2016, Vice President-U.S.
Operations & Investments at Reliance Capital Usa Ventures LLC from 2006 to 2009, and Chief Financial & Accounting Officer at Cidara Therapeutics, Inc. from 2024 to 2025.
Education includes a doctorate from the University of Mississippi Medical Center, an MBA from The Wharton School of the University of Pennsylvania, and an undergraduate degree from McDaniel College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-08 | 0 ( -.--% ) | - $ | 2026-05-30 |
Preetam Shah active positions
| Companies | Position | Start |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Director of Finance/CFO | 2025-03-23 |
Former positions of Preetam Shah
| Companies | Position | End |
|---|---|---|
| CIDARA THERAPEUTICS | Director of Finance/CFO | 2025-02-23 |
| BRAINSTORM CELL THERAPEUTICS INC. | Director of Finance/CFO | 2021-08-30 |
Canaccord Genuity, Inc.
 Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 2015-12-31 |
Saisarva LLC | Founder | 2012-12-31 |
Reliance Capital Usa Ventures LLC | Chief Investment Officer | 2008-12-31 |
Training of Preetam Shah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
11
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Barclays Capital, Inc.
 Barclays Capital, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McDaniel College
 McDaniel College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lordes Capital Ltd.
 Lordes Capital Ltd. Investment Banks/BrokersFinance Provides investment banking and advisory services | Finance |
University of Mississippi Medical Center
 University of Mississippi Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Canaccord Genuity, Inc.
Canaccord Genuity, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Reliance Capital Usa Ventures LLC | |
Saisarva LLC | |
Elicio Therapeutics, Inc.
 Elicio Therapeutics, Inc. BiotechnologyHealth Technology Develops cancer immunotherapies | Health Technology |
- Stock Market
- Insiders
- Preetam Shah
